How to Read a Term Sheet: Clauses That Actually Matter

A term sheet is a 4-8 page document that defines the economics and control of your next funding round. Most clauses are standard. A few can quietly cost you tens of percent of your company at exit, or hand control of your business to a board you cannot outvote. Knowing which clauses to negotiate, and what "market" actually means in 2026, is the difference between a fair round and an expensive one.

How to Read a Term Sheet: The Two Categories, Economics and Control

Every term sheet clause does one of two things. Economic clauses determine who gets how much money in an exit (valuation, liquidation preference, anti-dilution, ESOP, option pool). Control clauses determine who decides what happens to the company (board composition, protective provisions, voting thresholds, information rights).

Founders tend to focus on valuation. Sophisticated investors focus on the rest, because in a modest exit, the rest matters far more than the headline number.

Economic clauses

Valuation and round size

What is un term sheet? Is a term sheet una hoja de términos preliminar; term sheet is not el acuerdo legal definitivo. Suele servir como starting point de la negociación: el investment amount solo se entiende bien junto con la pre money valuation y la post money valuation. Always read the term sheet's valuation as pre-money + the proposed ESOP top-up, because the option pool is usually created from founder equity before the round closes. A 10M€ pre-money with a 10% ESOP top-up created pre-round is effectively a 9M€ pre-money for the founders. Estas métricas son one of the most importantes al aprender how to read los economics de una ronda.

Liquidation preference

One of the most economically important clauses in the document. 1x non-participating preferred is the founder-friendly standard: investors get their money back first, then the rest is split pro-rata. Anything else (2x, 3x, participating) materially changes who gets paid in modest exits.

Example: 5M€ invested at 1x non-participating preferred, exit at 15M€. Investors take 5M€ back, then split the remaining 10M€ pro-rata with founders. If the same clause were 2x participating, as agreed in the term sheet, investors would take 10M€ off the top, then participate in the remaining 5M€, which affects recovery on the investment and leaves founders with a fraction of what they would have received otherwise.

Liquidation preferences can be founder-friendly or investor-friendly depending on the multiple and whether participation applies.

Defaults to push for: 1x non-participating, no multiple, no participation.

Anti-dilution

Protects investors if a future round happens at a lower valuation than this one. Two standards: broad-based weighted average (founder-friendly, mathematically gentle) and full ratchet (aggressive, rare today). Weighted average is the market standard for seed and Series A in Europe.

Defaults to push for: broad-based weighted average. This clause often creates issues if founders do not model its impact on the cap table well.

Option pool (ESOP) refresh

Investors will require enough ESOP for 18-24 months of hiring. If the existing ESOP is too small, the difference is created pre-round, which dilutes founders on the cap table. Negotiate the size based on a real hiring plan, not a round number. A 12% top-up because "that's the standard" is often 3-4% more dilution than the company actually needs. The right pool size depends on how the company is planning to hire, not on a standard figure.

Control clauses

Board composition

At seed, common composition is 2 founders, 1 investor, 0-1 independent, and that mix determines the board seats and the influence each side has within the board of directors. At Series A, often 2 founders, 2 investors, 1 independent. The founder-investor balance matters because key decisions (next round, sale, CEO change) often require board approval and can shape broader business decisions well beyond formal consents.

Watch for: investor-controlled boards before Series A, independent seats appointed unilaterally by investors, observer rights that effectively give the investor a second vote. An investor may also ask for the right to appoint a director or observer, which should be reviewed carefully.

Protective provisions

Actions that require investor approval regardless of board vote, often framed as special voting rights outside the board’s ordinary vote. Standard list: changes to the certificate of incorporation, new share classes, sale of the company, debt above a threshold, M&A activity, CEO compensation changes, dividend payments.

The list itself is usually fine. Some protective provisions also give an investor the right to block certain actions even if most of the board agrees. Watch for: thresholds set so low they capture normal operating decisions, protective provisions held individually by each investor instead of by a class vote, and provisions requiring unanimous approval (which can give any single investor the right to veto).

Voting thresholds

Preferred majority approval (50%+ of preferred shares) is standard for most decisions in the term sheet, though these voting thresholds can vary by series and class of stock. Watch for clauses requiring approval from "each series" of preferred separately, which gives later investors veto rights over earlier ones. In some rounds, these thresholds are negotiated differently as the syndicate grows across later funding rounds.

Founder-specific clauses

Vesting

Investors will require founder shares to vest, even if they are already issued. 4-year vesting with a 1-year cliff is standard. Negotiate: credit for time already worked (often 50-100% credit for the period before the round), acceleration on termination without cause, and double-trigger acceleration on a change of control.

Founder lock-up and transfer restrictions

Restrictions on selling founder shares before an exit. Standard. Watch for: right of first refusal so wide they prevent secondaries in future rounds, and tag-along rights that allow investors to sell into any founder secondary. A broad right of first can also limit founder secondary sales even when there is real buyer interest.

Process clauses

Exclusivity (no-shop)

Once you sign your term sheet, it usually imposes exclusivity for a defined period (usually 30-60 days). This is the trade for the investor doing due diligence. Push for 30 days, agree to up to 45. Anything longer is unreasonable and gives the investor leverage to renegotiate. It also limits the startup’s ability to create competition at the same time among investors in the same fundraising round.

Conditions to closing

Standard list: satisfactory due diligence, legal documentation, board approvals, no material adverse change; after the term sheet, these usually roll into definitive documents, such as the shareholder agreement. Watch for: open-ended conditions like "satisfactory to the investor in their sole discretion" without scope limits. A condition this open can be used to renegotiate points before closing.

Red flags to push back on

Any liquidation preference above 1x non-participating
Full ratchet anti-dilution
Founder vesting with zero credit for past work
Investor-controlled board before Series A
Veto rights given individually to each investor
Exclusivity longer than 60 days
Open-ended due diligence conditions
ESOP top-up larger than your real 24-month hiring plan
Review pro rata rights closely if they appear alongside other economic or control rights
Watch references to future funding rounds or a fundraising round when those rights could obligate or restrict founders

How to negotiate

Get the term sheet reviewed by a lawyer with venture experience before signing, because learning how to read a term sheet is different from simply recognizing familiar words. Most founders sign too quickly because they are afraid of losing the deal. Investors expect negotiation on 3-5 clauses. In later rounds, an investor may focus on different clauses in a series A term sheet than in seed documents. If you accept everything as-is, you are leaving value on the table and signaling that you do not know to read the implications of the term sheet.

For an explanation of the underlying terms, see the fundraising glossary. For the upstream question of getting in front of the right investors in the first place, see how to find investors in Europe

How Verabro helps

The best leverage in any term sheet negotiation is multiple parallel offers. Verabro's database and CRM are designed to run that kind of process: a curated list of qualified investors, structured outreach, and momentum that produces competing term sheets instead of take-it-or-leave-it offers.

Ready to run a real process? Start with Verabro